Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Lancet Diabetes Endocrinol. 2018 Apr 21;6(7):555–563. doi: 10.1016/S2213-8587(18)30099-8

Figure 5.

Figure 5

Panel A: Incidence rates of CKD per 100 person-years of follow-up for the entire duration of the study in the intensive and standard SBP groups in SPRINT and ACCORD BP participants with urinary ACR < 3.4 mg/mmol or ≥ 3.4 mg/mmol

Panel B: Hazard ratios for incident CKD (intensive versus standard SBP group) in SPRINT and ACCORD BP participants with urinary ACR < 3.4 mg/mmol or ≥ 3.4 mg/mmol